Top compounds associated with response to TTYH3


Feature Type Standardized
Nominal ANOVA
mRNA FMK GDSC1000 pan-cancer AAC 0.056 0.2
mRNA B02 CTRPv2 pan-cancer AAC -0.058 0.2
mRNA Sorafenib CCLE pan-cancer AAC 0.074 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.2
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.045 0.2
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.13 0.2
mRNA XMD8-85 GDSC1000 pan-cancer AAC 0.077 0.2
mRNA ML162 CTRPv2 pan-cancer AAC -0.053 0.2
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.13 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
Download CSV